Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

This study compares the efficacy and safety of rivaroxaban versus warfarin for the prevention of stroke and non central nervous system embolism in subjects with non-valvular atrial fibrillation.